SlateStone Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,100
Closed -$209K 228
2023
Q2
$209K Hold
1,100
0.04% 202
2023
Q1
$220K Hold
1,100
0.05% 196
2022
Q4
$261K Hold
1,100
0.06% 168
2022
Q3
$220K Buy
+1,100
New +$220K 0.06% 177